4

OWNERSHIP DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: June 15, 2018
Period of Report: June 15, 2018
Accession Number: 0001213900-18-007754

View Document ↗ View on SEC.gov ↗